EVELO BIOSCIENCES INC (EVLO)

US2997342025 - Common Stock

0.3165  -0.05 (-14.46%)

After market: 0.3159 0 (-0.19%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
74.33M108.47M115.39M91.89M86.36M
Research and Development
53.48M78.55M83.64M69.62M63.13M
Selling, General, and Administrative Expenses
20.85M29.91M31.75M22.27M23.23M
Operating Income
-74.33M-108.47M-115.39M-91.89M-86.36M
Interest Income/Expense
-4.86M-4.67M-3.61M-2.11M1.05M
Other Income/Expense
680.00K60.00K490.00K740.00K30.00K
Non Recurring Items
N/A-520.00K-3.23MN/AN/A
Income Before Taxes
-81.45M-113.60M-121.75M-93.26M-85.28M
Income Tax
900.00K930.00K430.00K410.00K190.00K
Net Income
-82.34M-114.53M-122.18M-93.67M-85.47M
EBITDA
-72.77M-106.41M-113.17M-89.86M-84.60M
 
Per Share Data
EPS Diluted Total Ops
-13.34-26.28-46.10-47.54-53.41
Non GAAP EPS
N/A-29.00-12.51-2.41-2.66
 
Statistics

All data in USD

Charts